LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 48 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | -25.0% | 33,907 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | -47.8% | 33,907 | 0.0% | 0.00% | – |
| Q1 2022 | $23,000 | -70.5% | 33,907 | 0.0% | 0.00% | – |
| Q4 2021 | $78,000 | -49.7% | 33,907 | 0.0% | 0.00% | – |
| Q3 2021 | $155,000 | +40.9% | 33,907 | +36.7% | 0.00% | – |
| Q2 2021 | $110,000 | -93.5% | 24,807 | -89.4% | 0.00% | – |
| Q1 2021 | $1,700,000 | +3.7% | 233,539 | +8.7% | 0.00% | – |
| Q4 2020 | $1,639,000 | +14.5% | 214,758 | +36.2% | 0.00% | – |
| Q3 2020 | $1,432,000 | +7.1% | 157,665 | -0.3% | 0.00% | – |
| Q2 2020 | $1,337,000 | +112.6% | 158,085 | +24.2% | 0.00% | – |
| Q1 2020 | $629,000 | -31.5% | 127,240 | -0.2% | 0.00% | – |
| Q4 2019 | $918,000 | -28.8% | 127,448 | +6.9% | 0.00% | – |
| Q3 2019 | $1,289,000 | -17.3% | 119,273 | -0.5% | 0.00% | – |
| Q2 2019 | $1,559,000 | +130.6% | 119,925 | +75.2% | 0.00% | – |
| Q1 2019 | $676,000 | +8.2% | 68,447 | +13.9% | 0.00% | – |
| Q4 2018 | $625,000 | – | 60,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 8,466,783 | $5,758,000 | 0.09% |
| HARBOR CAPITAL ADVISORS, INC. | 226,731 | $154,000 | 0.07% |
| Sio Capital Management, LLC | 182,630 | $124,000 | 0.04% |
| Virtu Financial LLC | 71,475 | $49,000 | 0.00% |
| Independence Bank of Kentucky | 10,200 | $7,000 | 0.00% |
| SANDERS MORRIS HARRIS LLC | 15,000 | $10,000 | 0.00% |
| Endurance Wealth Management, Inc. | 1,500 | $12,000 | 0.00% |
| Baker Brothers Advisors | 451,478 | $307,000 | 0.00% |
| Texas Yale Capital Corp. | 20,000 | $14,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 79,900 | $54,000 | 0.00% |